Equities

BioRegenx Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BRGX:PKC

BioRegenx Inc

Actions
Consumer DiscretionaryMedia
  • Price (USD)0.0104
  • Today's Change-0.004 / -25.71%
  • Shares traded60.20k
  • 1 Year change-28.28%
  • Beta-3.1982
Data delayed at least 15 minutes, as of Feb 13 2026 14:48 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BioRegenx, Inc. operates as a holding company specializing in acquiring intellectual property (IP) and companies engaged in regenerative biotherapeutics and anti-aging research. The Company’s subsidiaries include DocSun BioMedical Holdings, Inc. (DocSun), Microvascular Health Solutions, LLC (MVHS), MyBodyRx, LLC (MyBodyRx), NuLife Sciences, Inc. (NuLife) and Findit Ai Connect, Inc. (Findit Ai). DocSun combines three technologies in the DocSun Artificial Intelligence (AI) Engine. The DocSun AI Engine integrates advanced ballistocardiography, which can detect an individual's heartbeat without touch, and photoplethysmography, a method that uses light to track the flow of blood. MVHS specializes in research, product development, sales, and education, notably producing the patented Endocalyx Pro dietary supplement. MVHS also manufactures and distributes the patented GlycoCheck software and Class 1 medical devices. DocSun is also developing an app for NuLife, TruScan.Ai mobile app/Website.

  • Revenue in USD (TTM)1.93m
  • Net income in USD-18.93m
  • Incorporated1998
  • Employees5.00
  • Location
    BioRegenx Inc7407 Ziegler RoadCHATTANOOGA 37421United StatesUSA
  • Phone+1 (404) 443-3224
  • Fax+1 (702) 866-2689
  • Websitehttps://www.findit.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
QHSLab Inc2.61m-386.75k9.41m4.00------3.60-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
ALR Technologies SG Ltd9.49k-8.00m9.68m6.00------1,020.23-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
HeartSciences Inc8.67k-9.04m9.92m15.00--2.29--1,143.72-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
PAVmed Inc29.00k-595.00k10.24m39.0027.7828.04--352.95-0.6822-0.68220.00051.550.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
Movano Inc500.00k-17.05m10.42m32.00------20.84-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
SINTX Technologies Inc1.27m-16.56m10.48m20.00--2.42--8.25-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
Dror Ortho-Design Inc0.00-3.12m10.72m3.00---------0.0033-0.00330.00-0.00240.00----0.00-405.89-214.68---759.55-------276,220.70---69.87---------61.89------
Beyond Air Inc5.80m-36.70m10.74m61.00--0.6416--1.85-7.54-7.541.151.590.13822.608.0195,114.76-89.86-81.28-105.60-103.40-6.70---650.33-4,167.723.73-16.500.4351--219.6721.6622.60--166.66--
BioNano Genomics Inc28.72m-38.59m11.09m98.00--0.213--0.3862-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
REMSleep Holdings Inc12.27k-3.01m12.13m6.00--50.30--988.79-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
Vicarious Surgical Inc0.00-53.59m12.60m123.00--0.7488-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
BioRegenx Inc1.93m-18.93m13.47m5.00------6.98-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
Trinity Biotech PLC (ADR)49.41m-35.91m14.50m401.00------0.2934-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
Vivos Therapeutics Inc17.32m-17.10m14.63m109.00--5.06--0.8448-1.88-1.881.930.30630.8449--13.38158,871.60-83.45-85.27-120.33-138.5155.7467.27-98.77-108.16----0.7785--8.915.7018.02--26.46--
Envoy Medical Inc208.00k-28.61m15.09m42.00------72.56-1.44-1.440.0103-0.32180.02370.501.794,952.38-247.90-------294.23---10,475.00--0.4582-14.86-----28.80--10.55------
United Health Products Inc0.00-2.95m15.90m10.00---------0.0116-0.01160.00-0.01290.00----0.00-2,405.94-4,956.01-----------137,625.90---16.29--------23.69------
Data as of Feb 13 2026. Currency figures normalised to BioRegenx Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.